chaetocin and Stomach-Neoplasms

chaetocin has been researched along with Stomach-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for chaetocin and Stomach-Neoplasms

Article	Year
ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell death & disease, 2019, 10-24, Volume: 10, Issue:11 Topics: Animals; Antineoplastic Agents; Auranofin; Cell Death; Cell Line, Tumor; Heterografts; Humans; Mice; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Stomach Neoplasms; Thioredoxin Reductase 1; Thioredoxins	2019

Article

Year

ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin.

Cell death & disease, 2019, 10-24, Volume: 10, Issue:11

Topics: Animals; Antineoplastic Agents; Auranofin; Cell Death; Cell Line, Tumor; Heterografts; Humans; Mice; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Stomach Neoplasms; Thioredoxin Reductase 1; Thioredoxins

2019